MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next
Thileepan Naren, Suzanne Nielsen, Myfanwy Graham
au (code pays fourni par la source)
0 citations
Myfanwy Graham
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
35Publications signalées
320Citations signalées
4Affiliations récentes
Les institutions déclarées
Les domaines associés
Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesPsychedelics and Drug StudiesForensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment
Les publications récentes
A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study
Myfanwy Graham, Yimin Ge, Rosalie Liccardo Pacula, Seema Choksy Pessar et autres
au, us, nz, ca (code pays fourni par la source)
1 citation
International Journal of Drug Policy
Higher-strength medicinal cannabis may be linked to a disturbing pattern of side effects, our study shows
Myfanwy Graham, Suzanne Nielsen
au (code pays fourni par la source)
0 citations
A retrospective analysis of voluntary adverse event reports to the TGA with higher THC medicinal cannabis products
Myfanwy Graham, Calvert Tisdale, Suzanne Nielsen
au (code pays fourni par la source)
4 citations
Australian & New Zealand Journal of Psychiatry
Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review
Myfanwy Graham, Dereje Zewdu Assefa, Ngo Cong‐Lem, Suzanne Nielsen
au, us (code pays fourni par la source)
4 citations
Drug and Alcohol Review
Will medicinal cannabis help my mental health? Here are the evidence and the risks
Suzanne Nielsen, Myfanwy Graham
au (code pays fourni par la source)
0 citations
The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis
Jack Wilson, Olivia Dobson, Andrew Langcake, Palkesh Mishra et autres
au, gb (code pays fourni par la source)
24 citations
The Lancet Psychiatry
Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects
Maria Antonietta De Luca, Cristina Miliano, Amanda Roxburgh, Myfanwy Graham et autres
gb, it, us, au (code pays fourni par la source)
1 citation
Current Neuropharmacology
Medicinal cannabis is most often prescribed for pain, anxiety and sleep. Here’s what the evidence says
Suzanne Nielsen, Myfanwy Graham
au (code pays fourni par la source)
0 citations
Understanding medical cannabis use internationally: Why definitions and context matter
Myfanwy Graham, Rosalie Liccardo Pacula, Seema Choksy Pessar, Yimin Ge et autres
us, au, ca (code pays fourni par la source)
7 citations
Addiction
International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA
Myfanwy Graham, Wayne Hall, Rosalie Liccardo Pacula, David Hammond
au, us, ca (code pays fourni par la source)
0 citations
Drug and Alcohol Dependence
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis
Jack Wilson, Andrew Langcake, Zachary Bryant, Tom P. Freeman et autres
au, gb (code pays fourni par la source)
0 citations
Systematic Reviews
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.